The Division works continually to improve quality of life for patients with vascular diseases. We are privileged to work with an outstanding team of faculty and community vascular specialists, cardiologists and cardiac surgeons, radiologists, podiatrists, rehabilitation specialists, basic scientists, engineers and computer scientists. Our ongoing collaborations have promoted remarkable academic and clinical productivity involving new and dramatically improved techniques for the diagnosis and treatment of vascular disease, gaining the Division international recognition as a Vascular Center of Excellence.
The faculty is distinguished by expertise in many aspects of vascular disease management, but perhaps none more so than aortic aneurysm disease. Stanford Vascular Surgeons are recognized around the world as leaders in aortic aneurysm treatment and research.
Dr. Dalman discusses “the epidemic” of burnout and how to effectively build a career in vascular surgery at the London Aortic Symposium 2018, where he gave a keynote lecture focusing on his advice for the future.
Dr. Dalman Named Associate Dean for Market Development
In this new role, Dr. Dalman will serve as faculty dyad for Stanford Health Care market and business development leadership and clinical chairs, chiefs, and staff working to identify and optimize network and affiliation agreements across the region to achieve established goals of the Integrated Strategic Plan.
Headline News: Thoracic Outlet Syndrome
Dr. Jason T. Lee, Professor of Sugery, Division of Vascular Surgery uses his 15 years of experience to discusses thoracic outlet syndrome.
Stanford Faculty Leading Top National Organizations
Dr. Ronald Dalman, Chief, Division of Vascular Surgery, is one of four distinguished Stanford School of Medicine faculty appointed to prominent national health care organizations in the field of cardiovascular medicine. Dr. Dalman is the Vice President of the Society for Vascular Surgery (SVS) for the 2018-2019 academic year. Dr. Dalman will serve as President-Elect (2019-2020) followed by President (2020-2021) .